Insider Transactions in Q3 2022 at Jounce Therapeutics, Inc. (JNCE)

JNCE Quotes by TradingView

Insider Transaction List (Q3 2022)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Aug 01 2022
Hugh M Cole Chief Operating Officer
BUY
Grant, award, or other acquisition
Direct
20,000 +13.63%
-

Track Institutional and Insider Activities on JNCE

Follow Jounce Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNCE shares.

Notify only if

Insider Trading

Get notified when an Jounce Therapeutics, Inc. insider buys or sells JNCE shares.

Notify only if

News

Receive news related to Jounce Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNCE